Comparing Outcomes of Two Antiviral Therapy Combinations among COVID-19 Patients

Table 3

The outcome of two different combination therapies among COVID-19 patients.

		Lopinavir/ritonavir; (%)	Atazanavir/ritonavir; (%)	value
Arrhythmia		28 (63.6)	16 (36.4)	0.019
End of treatment	Discharge	41 (47.7)	45 (52.3)	0.633
	Complication	10 (58.8)	7 (41.20)
	Expired	3 (60)	2 (40)

Bold value indicates statistical significance.